Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-24

Clinical Trial Update: Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating fish oil (omega-3 fatty acids) and diet for nonalcoholic steatohepatitis (NASH) and hepatic steatosis was terminated, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish oil

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Nonalcoholic Steatohepatitis (NASH), Hepatic Steatosis | Phase 2 | Status: TERMINATED | Results posted: 2013-07-24